These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19025708)

  • 1. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of budesonide inhalation suspension with four nebulizing solutions.
    McKenzie JE; Cruz-Rivera M
    Ann Pharmacother; 2004 Jun; 38(6):967-72. PubMed ID: 15084687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical-chemical compatibility of cromolyn sodium nebulizer solution--bronchodilator inhalant solution admixtures.
    Lesko LJ; Miller AK
    Ann Allergy; 1984 Sep; 53(3):236-8. PubMed ID: 6433752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures.
    Emm T; Metcalf JE; Lesko LJ; Chai MF
    Ann Allergy; 1991 Feb; 66(2):185-9. PubMed ID: 1899784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
    Krämer I; Schwabe A; Lichtinghagen R; Kamin W
    Pharmazie; 2007 Oct; 62(10):760-6. PubMed ID: 18236781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
    Bonasia P; Cook C; Cheng Y; Ong S
    Curr Med Res Opin; 2007 Oct; 23(10):2477-83. PubMed ID: 17784997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical compatibility of nebulizable drug admixtures containing budesonide and colistimethate or hypertonic saline.
    Klemmer A; Krämer I; Kamin W
    Int J Pharm Compd; 2013; 17(3):254-61. PubMed ID: 24046941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
    Kamin W; Schwabe A; Krämer I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):599-607. PubMed ID: 18268934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on aerosol performance of mixing of either budesonide or beclomethasone dipropionate with albuterol and ipratropium bromide.
    Melani AS
    Respir Care; 2011 Mar; 56(3):319-26. PubMed ID: 21255509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of nebulizer solution admixtures.
    Joseph JC
    Ann Pharmacother; 1997 Apr; 31(4):487-9. PubMed ID: 9101012
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of common nebulizer medications with 7% sodium chloride solution.
    Fox LM; Foushee JA; Jackson DJ; Watson H
    Am J Health Syst Pharm; 2011 Jun; 68(11):1032-5. PubMed ID: 21593232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
    Walker SE; DeAngelis C; Iazzetta J; Eppel JG
    Am J Hosp Pharm; 1991 Oct; 48(10):2161-6. PubMed ID: 1723578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a stability-indicating high-performance liquid chromatography method for the simultaneous determination of albuterol, budesonide, and ipratropium bromide in compounded nebulizer solutions.
    Blewett AJ; Varma D; Gilles T; Butcher R; Jacob J; Amazan J; Jansen SA
    J AOAC Int; 2011; 94(1):110-7. PubMed ID: 21391487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].
    Chen ZG; Li M; Chen H; Chen YF; Chen FH; Ji JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):470-2. PubMed ID: 18359717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol Characteristics and Physico-Chemical Compatibility of Combivent
    Zhang R; Hu J; Deng L; Li S; Chen X; Liu F; Wang S; Mohammed Abdul KS; Beng H; Tan W
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31963493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.